Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Posts Greater Revenue, Narrowed Loss in Q2

NEW YORK, Aug. 7 (GenomeWeb News) - Paradigm Genetics today reported a modest jump in second-quarter revenue atop declines in R&D spending a narrowed net loss.


Total revenue for the period ended June 30 increased to $5.6 million from $4.4 million year over year.


R&D spending dipped to $6.5 million from $7 million in the second-quarter 2002.


Consequently, net loss for the second quarter 2003 narrowed to $3.6 million, or $.11 per square, from $5 million, or $.16 per share, in the same period last year.


Paradigm said it had around 9.3 million in cash, cash equivalents and short-term investments as of June 30.


Click here for more information.


Last month, Paradigm pocketed $7.5 million as part of a  debt-financing deal with Silicon Valley Bank of Santa Clara, Calif. Paradigm said the financing includes a $5 million, four-year secured-term loan and a $2.5 million revolving line of credit. The firm added that the loan is at a "significantly lower [interest] rate" than its existing loan.


Paradigm, based in Research Triangle Park, NC, will use around $3 million of the term loan to pay off its current equipment financing loan with Transamerica Technology Finance, which was to mature in June 2004. The company said it will use the balance of the cash for "general corporate purposes."

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.